Generic Drug Battles Heat Up

Innovators and generics makers are staking out positions on follow-on proteins and other manufacturing issues.

Related Content:

Bio/Pharma BusinessManufacturingQuality SystemsRegulatory WatchGeneric DrugsDosage FormsPharmaceutical Technology-04-02-2005

EC Approves Vabysmo for Two Leading Causes of Vision Loss

Congress Slated to Reauthorize User Fees Without FDA “Improvements”

The Manufacturing Edge on Path to Market